| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BRD-K03536150 | CTRPv2 | pan-cancer | AAC | 0.19 | 3e-07 |
| mRNA | Parthenolide | CTRPv2 | pan-cancer | AAC | 0.19 | 1e-06 |
| mRNA | GMX-1778 | CTRPv2 | pan-cancer | AAC | 0.17 | 2e-06 |
| mRNA | Cytarabine | CTRPv2 | pan-cancer | AAC | 0.13 | 5e-06 |
| mRNA | VX-680 | CTRPv2 | pan-cancer | AAC | 0.41 | 5e-05 |
| mRNA | RG-108 | CTRPv2 | pan-cancer | AAC | 0.15 | 5e-05 |
| mRNA | BRD-K01737880 | CTRPv2 | pan-cancer | AAC | 0.44 | 8e-05 |
| mRNA | apicidin | CTRPv2 | pan-cancer | AAC | 0.12 | 9e-05 |
| mRNA | BRD-K35604418 | CTRPv2 | pan-cancer | AAC | 0.14 | 0.0001 |
| mRNA | tandutinib | CTRPv2 | pan-cancer | AAC | 0.13 | 0.0002 |